Galenica AG (SWX: GALE)
Switzerland
· Delayed Price · Currency is CHF 72.80
-0.60 (-0.82%)
Dec 19, 2024, 5:31 PM CET
Galenica AG Revenue
Galenica AG had revenue of 1.91B CHF in the half year ending June 30, 2024, with 8.20% growth. This brings the company's revenue in the last twelve months to 3.80B, up 2.99% year-over-year. In the year 2023, Galenica AG had annual revenue of 3.76B with 4.47% growth.
Revenue (ttm)
3.80B
Revenue Growth
+2.99%
P/S Ratio
0.96
Revenue / Employee
478.08K
Employees
7,902
Market Cap
3.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.76B | 160.81M | 4.47% |
| Dec 31, 2022 | 3.60B | -246.19M | -6.41% |
| Dec 31, 2021 | 3.84B | 356.57M | 10.23% |
| Dec 31, 2020 | 3.48B | 178.60M | 5.40% |
| Dec 31, 2019 | 3.31B | 134.90M | 4.25% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 60.58B |
| Roche Holding AG | 60.58B |
| Novartis AG | 42.18B |
| Lonza Group AG | 6.70B |
| Galderma Group AG | 3.88B |
| Straumann Holding AG | 2.54B |
| Sonova Holding AG | 3.71B |
| Ypsomed Holding AG | 617.07M |